MARKER THERAPEUTICS, INC. Gain (Loss) Related to Litigation Settlement
MARKER THERAPEUTICS, INC. (MRKR) reported Gain (Loss) Related to Litigation Settlement of -$24.70 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-04-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2016-04-14
- MARKER THERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2014-09-30 was -$94.64K.
- MARKER THERAPEUTICS, INC. gain (loss) related to litigation settlement for the quarter ending 2014-06-30 was $920.23K.
- MARKER THERAPEUTICS, INC. gain (loss) related to litigation settlement for fiscal 2015 was -$24.70K.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month | Gain (Loss) Related to Litigation Settlement 6 month | Gain (Loss) Related to Litigation Settlement 6 month as first filed | Gain (Loss) Related to Litigation Settlement 9 month | Gain (Loss) Related to Litigation Settlement 9 month as first filed | Gain (Loss) Related to Litigation Settlement 12 month |
|---|---|---|---|---|---|---|
| 2015-12-31 | -$24.70K 10-K · filed 2016-04-14 | |||||
| 2015-06-30 | $0.00 10-Q/A · filed 2016-04-14 | $0.00 10-Q/A · filed 2016-04-14 | ||||
| 2014-09-30 | -$94.64K 10-Q/A · filed 2016-04-14 | $825.59K derived: sum of 2 quarters · filed 2016-04-14 | -$26.84M 10-Q/A · filed 2016-04-14 | $2.94M 10-Q · filed 2014-11-19 | ||
| 2014-06-30 | $920.23K 10-Q/A · filed 2016-04-14 | -$26.74M 10-Q/A · filed 2016-04-14 | $2.91M 10-Q · filed 2014-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |